BCIQ Profiles

Company Profile Report
0308 QTs
BioCentury & Getty Images

Deals

March 8 Quick Takes: Roivant to acquire Immunovant; plus Lilly-Biolojic, Soleno, Gilead, Genentech and Cara-Vifor

Mar 8, 2021 | 11:06 PM GMT

Immunovant Inc. (NASDAQ:IMVT) rose $1.88 (14%) to $15.39 on Monday after the autoimmune company said parent Roivant Sciences

Read the full 424 word article

How to gain access

Continue reading with a
two-week free trial.